The e.l.f. Beauty story
e.l.f. Beauty makes accessible cosmetics and skincare, with the central question whether rhode and its core brands can sustain profit growth beyond tariff refunds.
Written from e.l.f. Beauty's own filings with the SEC, and rewritten when it publishes a new earnings release. Updated 2026-09-30.
- $101.80share price, last close
- $6.0Bmarket value
- 18/36TenQ Score checks passed
- 14.0%growth a year the price assumes
The story in brief
- Refunds lift margins. In the quarter to June 2026, gross margin reached 83%, with approximately 1,050 basis points of the approximately 1,400 basis points increase coming from IEEPA tariff refunds.
- Rhode exceeds thresholds. Rhode’s revenue outperformance against acquisition earnout thresholds prompted a $16.1 million adjustment to contingent consideration in the quarter to June 2026.
- Debt rises sharply. At June 30, 2026, total debt was $834.2 million versus $256.7 million a year earlier, while cash and cash equivalents reached $344.2 million.
What drives the business
- e.l.f. Beauty’s core model combines accessible pricing, frequent product innovation and digital marketing, with e.l.f. Cosmetics averaging approximately $7 per product in the United States versus $10 for other leading mass cosmetics brands and $30 for prestige brands.
- Its expansion into skincare includes rhode and Naturium, acquired for $898 million and $333 million, respectively, alongside e.l.f. SKIN and Well People.
- Retail relationships anchor distribution: the largest customer accounted for 18% of net sales in the fiscal year ended March 31, 2026, followed by Walmart at 13%, Amazon at 11% and Sephora at 10%.
- Marketing and digital expenses totaled $399.8 million, approximately 24% of net sales, in the fiscal year ended March 31, 2026, supporting a strategy focused on younger consumers and digital engagement.
- Net sales grew 36% to $479.4 million in the quarter to June 2026, with growth across retailer and e-commerce channels in both the United States and international markets.
What the price assumes
At $101.80, the reverse DCF implies free cash flow after stock pay growing 14.0% annually for ten years, using a 10.2% discount rate.
That compares with delivered growth of 13.2% annually over the last 3 fiscal years and the TenQ check’s 8.6% bar, which slows the historical record halfway toward 4%.
The implied growth requirement exceeds both comparisons, while free cash flow over the last twelve months was $280 million before accounting for $97 million of stock-based pay.
What could change the story
- The tariff refund benefit complicates comparisons with ongoing profitability, and manufacturing concentrated primarily in China leaves the cost structure exposed to tariff changes.
- Operating expenses can absorb strong product demand: selling, general and administrative expenses increased $84.5 million to $280.3 million in the quarter to June 2026, reflecting higher marketing, merchandising, distribution and other costs.
- Over the last twelve months, revenue growth of 31.2% trailed the three-year annual pace of 41.4%, while profit growth was -39.1%, failing the TenQ checks for accelerating growth and rising profits.
- Higher debt adds pressure to earnings coverage of interest, which measured 3.41 against the TenQ check’s 5.00 bar.
- Major retail customers have no obligation to continue purchasing products, and changes in their holiday orders or shelf resets can materially affect sales and liquidity.
What to watch next
- The raised fiscal 2027 outlook calls for net sales of $1,938-1,968 million, representing 18-20% growth, and adjusted EBITDA of $401-407 million.
- Subsequent releases will show whether pricing and lower tariff rates support gross margin apart from refunds, and whether expense growth moderates relative to revenue.
- Rhode’s revenue performance, further earnout adjustments and the movement of debt relative to cash will help distinguish brand momentum from its financial costs.
Sources
- e.l.f. Beauty's earnings release, filed with the SEC
- Its latest 10-Q or 10-K, for the risk factors
- The ELF stock report, for every figure and check